Strides Nordic ApS
Private limited companyCVR 40533605FrederiksbergActive
Strides Nordic ApS is a private limited company, based in Frederiksberg, active in wholesale of pharmaceutical goods and nursing supplies, founded in 2019. Equity was negative at the end of 2026 (−DKK 3.4m). The company made a loss in both 2025 and 2026, most recently DKK 5.7m. 8 other companies in the database are registered at the same address.
Key figures · financial year 2026
What has changed
calculated from recorded figures and datesFinancials: 2026 against 2025
- Gross profit rose 61% (2025 → 2026), to DKK 416k.
- The loss grew: from DKK 3.1m to DKK 5.7m (2025 → 2026).
- Equity turned negative: −DKK 3.4m (2025 → 2026).
Employees
- 1 more employees than a year earlier: 5 (07/2026) against 4 (07/2025).
Registrations, last 24 months
- 16/04/2026: Moved to Nordre Fasanvej 215, 2000 Frederiksberg
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2021–2026 · amounts in DKK thousandEquity and net profit
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Change | |
|---|---|---|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | not stated | not stated | not stated | – |
| Gross profit | 782 | −1,798 | 9,524 | 3,431 | 259 | 416 | +60.9% |
| Operating profit (EBIT) | 782 | −2,232 | 7,938 | 915 | −4,053 | −4,409 | −8.8% |
| Profit before tax | 765 | −2,272 | 7,750 | 440 | −4,207 | −4,456 | −5.9% |
| Net profit | 596 | −1,776 | 6,043 | 331 | −3,129 | −5,658 | −80.8% |
| Total assets | 12,786 | 25,741 | 38,841 | 33,323 | 55,244 | 82,865 | +50% |
| Equity | 758 | −1,018 | 5,026 | 5,357 | 2,228 | −3,431 | −254% |
| Liabilities | 12,028 | 26,759 | 33,815 | 27,966 | 53,017 | 86,296 | +62.8% |
| Cash and cash equivalents | 0 | 14 | 774 | 2,020 | 1,322 | 3,465 | +162.2% |
| Average number of employees | – | 0 | 0 | 0 | 3 | 4 | +33.3% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2021, 2022, 2023, 2024, 2025, 2026: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2026 figuresNegative equity
Equity was −DKK 3.4m at the end of 2026.
How is this calculated?
Equity in the latest annual report is below zero.
Loss for 2 years in a row
Net result has been negative in 2025–2026.
How is this calculated?
Net result is negative in the two or more latest annual reports in a row.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
6 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2026 | 01/04/2025 – 31/03/2026 | 30/09/2026 | The company | PDF not statedXBRL |
| 2025 | 01/04/2024 – 31/03/2025 | 28/08/2025 | The company | PDF not statedXBRL |
| 2024 | 01/04/2023 – 31/03/2024 | 13/06/2024 | The company | PDFXBRL |
| 2023 | 01/04/2022 – 31/03/2023 | 09/06/2023 | The company | PDFXBRL |
| 2022 | 01/04/2021 – 31/03/2022 | 21/09/2022 | The company | PDFXBRL |
| 2021 | 01/04/2020 – 31/03/2021 | 27/08/2021 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
232 companies in the databaseComparison with the other companies in wholesale of pharmaceutical goods and nursing supplies based on the latest financial year.
Industry median: gross profit DKK 11.2m, net profit DKK 1.8m, equity DKK 9.6m, 9 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 55,757of 69,742 Better than 20% | No. 68,846of 69,964 Better than 2% |
| Same industry and fewer than 20 employees150 companies in the comparison | No. 137of 150 Better than 9% | No. 147of 150 Better than 2% |
| Companies that are between 5 and 14 years old33,688 companies in the comparison | No. 28,247of 33,588 Better than 16% | No. 32,861of 33,687 Better than 2% |
| All companies of type ApS66,508 companies in the comparison | No. 53,642of 66,379 Better than 19% | No. 65,382of 66,505 Better than 2% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Wholesale of pharmaceutical goods and nursing supplies- Strides Nordic ApSDKK 416k
- Ambu A/SDKK 3.6bn
- Stada Nordic ApSDKK 687m
- Strides Nordic ApS−DKK 5.7m
- Ambu A/SDKK 609m
- Stada Nordic ApSDKK 54.6m
- Strides Nordic ApS−DKK 3.4m
- Ambu A/SDKK 6bn
- Stada Nordic ApSDKK 346.3m
- Strides Nordic ApS5
- Ambu A/S619
- Stada Nordic ApS51
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Strides Pharma Global PTE. Limited100%
Management
2 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Amol Jyotirvadan Mehta | Director | 01/05/2022 |
| Christian Köse Fischer | CEO | 27/05/2024 |
- Founders
- Øresund Pharma ApS
Former management (1)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Patrick Halborg Cohn | CEO | 02/05/2019 | 23/05/2024 |
Signing rule: Virksomheden tegnes af en direktør alene.
Address and production units
1 active production unitsNordre Fasanvej 215
2000 Frederiksberg
Frederiksberg Municipality · Postcode 2000
Other companies at the address (8)
- Sparrow Quantum ApSManufacture of computers and peripheral equipment
- Adcendo ApSResearch and experimental development on natural sciences and engineering
- Hemab ApSManufacture of pharmaceutical preparations
- Orbis Medicines ApSResearch and experimental development on natural sciences and engineering
- Minervax ApSResearch and experimental development on natural sciences and engineering
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Strides Nordic ApS | Nordre Fasanvej 215, 2000 Frederiksberg | 6 | 1024720957 |
Purpose
Selskabets formål er at udvikle og kommercialisere farmaceutiske lægemidler og dermed forbunden virksomhed.
The purpose is quoted from the register in Danish.
Changes year by year
17 registered events20262 changesaccounts 1 · address 1
- AccountsAnnual report for 2026 published
- AddressMoved to Nordre Fasanvej 215, 2000 Frederiksberg
20251 changeaccounts 1
- AccountsAnnual report for 2025 published
20244 changesaccounts 1 · address 1 · management 2
- AccountsAnnual report for 2024 published
- AddressMoved to Fuglevangsvej 11, 1962 Frederiksberg C
- ManagementChristian Köse Fischer appointed ceo
- ManagementPatrick Halborg Cohn stepped down as ceo
20231 changeaccounts 1
- AccountsAnnual report for 2023 published
20222 changesaccounts 1 · management 1
- AccountsAnnual report for 2022 published
- ManagementAmol Jyotirvadan Mehta appointed director
20211 changeaccounts 1
- AccountsAnnual report for 2021 published
20196 changesownership 3 · address 1 · founded 1 · management 1
- OwnershipStrides Pharma Global PTE. Limited registered as owner (100%)
- OwnershipØresund Pharma ApS is no longer registered as owner
- AddressMoved to Dronningens Tværgade 9, 3, 1302 København K
- FoundedRegistered as Strides Nordic ApS
- ManagementPatrick Halborg Cohn appointed ceo
- OwnershipØresund Pharma ApS registered as owner (100%)
Related companies
Same industry in Frederiksberg
- Zentiva Denmark ApS16 employees
- Incyte Biosciences Denmark ApS4 employees
- Liofilchem Nordics ApS2 employees
Same people in management
- Øresund Pharma ApSvia Patrick Halborg Cohn
- Axel Mattsson's Rideskole & Hestepension ApSvia Patrick Halborg Cohn
Largest in the industry
- Ambu A/SDKK 3.6bn
- Stada Nordic ApSDKK 687m
- Nomeco A/SDKK 683m
- Orifarm Supply A/SDKK 538.5m
- Novo Nordisk Denmark A/SDKK 497.5m
- Sandoz A/SDKK 260.2m
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.